News from Tunnell Consulting

I don't know about you but I am so glad that Spring is finally here. It's so nice to spend more time outside and soak in some vitamin D. The arrival of Spring also means....it's golf season! Tunnell is very proud to be a sponsor of PA Biotech's inaugural golf outing. We're looking forward to meeting new people who share the same passion for emerging life sciences companies...as well as golf! We're also looking forward to upcoming events with Life Sciences PA and Parenteral Drug Association and we hope we may see you there too.

We hope you continue to stay safe and healthy!

We are delighted that Melissa Allensworth joined the Tunnell team recently. She has extensive experience in clinical development from pre-clinical/translational medicine to Phase 1-3 drug development and has been instrumental in facilitating virtual biotech models for early-stage clients. Her consulting services include protocol development and trial design, regulatory services (FDA, EMA and NMPA for pIND/IND submission), translational medicine, pharmacovigilance/safety, clinical operations, data management, and more. Utilizing a virtual biotech model, she has collaborated with early-stage clients to bring novel/first-in-human (FIH) assets to patients globally.

Melissa’s therapeutic experience includes Hematology/Oncology (blood and solid tumors) with modalities such as Small Molecules, Cell Therapies (CAR-T), Gene Therapies (AAV and Lenti), Immuno-Oncology, and Precision Medicine. She has also worked with leading experts in NASH/Liver Fibrosis and CNS therapies.